PDEX

Business Context and Reporting Period

Company: PRO-DEX, INC. (PDEX)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended June 30, 2026
Business Overview: Pro-Dex designs, develops, and manufactures autoclavable, battery-powered, and electric surgical drivers and shavers for orthopedic, thoracic, and craniomaxillofacial (CMF) markets. In February 2026, the company acquired Advanced Precision Machining, LLC ("APM"), expanding its capabilities to include precision machined parts for the aerospace and defense industries. The company operates as a single segment.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 16% to $77.5 million, driven primarily by a 30% increase in medical device sales ($62.1 million) due to the launch of a next-generation handpiece for the company's largest customer. This was partially offset by a 33% decline in repair revenue ($12.5 million) as customers transitioned away from legacy products.
• Acquisition Impact: The acquisition of APM in February 2026 contributed $0.7 million in revenue and added $6.5 million in goodwill. Industrial and scientific sales increased 76% due to APM's inclusion.
• Profitability: Gross margin improved from 29% to 31%. Net income increased 52% to $13.7 million, significantly boosted by a $9.1 million realized gain on the sale of the company's investment in Monogram Technologies (acquired by Zimmer Biomet).
• Customer Concentration: Concentration increased slightly; the top customer accounted for 78% of sales in 2026 (up from 75% in 2025). The top three customers accounted for 92% of total sales.
• Liquidity: Cash and cash equivalents surged from $0.4 million to $8.2 million, largely due to proceeds from the Monogram investment sale ($11.2 million) and strong operating cash flow.

Guidance, Outlook, and Risks

• Outlook: Management expects orthopedic sales to remain at similar levels through 2028 due to a contract extension with the largest customer. Repair revenue is expected to continue declining in the short term as the customer fully transitions to the new handpiece, though billable repairs for the new generation are expected to commence in fiscal 2027.
• Capital Allocation: The company repurchased 79,898 shares of common stock for $3.4 million during fiscal 2026. It maintains a revolving credit facility with $11.0 million available.
• Key Risks:
  • Customer Dependence: Loss of the largest customer (78% of sales) would have a material adverse effect.
  • Regulatory Compliance: The APM acquisition subjects the company to complex export controls (ITAR) and government contracting requirements.
  • Internal Controls: The company previously identified material weaknesses in internal controls (remediated as of June 30, 2026) and excludes APM from the current year's assessment.
  • Tariffs: Ongoing uncertainty regarding tariffs on imported raw materials could increase costs.

Investor Verification Checklist

• Monogram Gain Sustainability: Verify the extent to which the $9.1 million investment gain drives current profitability versus core operating earnings.
• Customer Contract Terms: Review the specific terms of the supply agreement with the largest customer (78% of revenue) extending through 2028.
• Repair Revenue Trajectory: Monitor the timeline for the decline in legacy repair revenue and the ramp-up of repairs for the next-generation handpiece.
• APM Integration: Assess the financial performance and regulatory compliance status of the newly acquired APM subsidiary.
• Debt Covenants: Confirm continued compliance with debt covenants, particularly given the increased debt load from the APM acquisition ($6.65 million Term Loan D).